Every material Form 8-K JATT II Acquisition Corp. has filed with the SEC since April 20, 2026, read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). Newest first; each brief links to its own page and to the filing on SEC.gov.
JATT II Acquisition Corp., a blank check company, entered a business combination agreement with Talawar Tx Inc., a biotechnology developer of bispecific antibodies. The combined company is expected to trade on Nasdaq as TLWR and to receive up to $285 million before transaction costs, including a $225 million PIPE financing at $10.00 per share, if there are no redemptions by JATT II shareholders.
Business combination agreement signed June 29, 2026; JATT II shareholders must approve the deal, and closing is expected in the second half of 2026
Expected proceeds of $285 million before transaction costs, assuming no redemptions: $60 million from the JATT II trust account plus a $225 million PIPE
Combined company expected to trade on Nasdaq Capital Market under ticker TLWR; lead asset TALA-125 targets clinic entry in Q1 2027
JATT II Acquisition Corp., a blank check company, closed its initial public offering of 6,000,000 ordinary shares at $10.00 per share on April 20, 2026, raising $60 million in gross proceeds, and a $3 million private placement to its sponsor closed at the same time. The full $60 million was deposited in a trust account for public shareholders, and the company has 24 months from the offering closing to complete a business combination, with no target selected yet.
IPO: 6,000,000 ordinary shares at $10.00 per share, $60 million gross proceeds, closed April 20, 2026
Private placement: 300,000 shares sold to JATT Ventures II L.P. for $3 million
Trust account: $60 million held with Continental Stock Transfer & Trust Company as trustee; redemption value $10.00 per public share
Underwriters hold a 45-day option to buy up to 900,000 additional shares at $10.00 per share
JATT II Acquisition Corp, a Cayman Islands blank check company, closed its initial public offering of 6,000,000 ordinary shares at $10.00 per share on April 20, 2026, for gross proceeds of $60 million. The company said $60 million from the IPO and a private placement to its sponsor was placed in a U.S.-based trust account, and funds will generally stay there until a business combination or a shareholder-approved redemption, with a 24-month deadline to complete a business combination.
IPO of 6,000,000 ordinary shares at $10.00 per share, generating $60,000,000 in gross proceeds; underwriters have a 45-day option to buy up to 900,000 more shares
Private placement of 300,000 shares to sponsor JATT Ventures II L.P. at $10.00 per share, generating $3,000,000
Trust account holds $60,000,000; if no business combination is completed within 24 months of the IPO closing, public shares are to be redeemed
Ordinary shares began trading on Nasdaq under the ticker JATT on April 17, 2026; Verender S. Badial, Christopher Staral, Arjun Goyal and Jonathon Kluft were appointed independent directors on April 16, 2026
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Only material 8-Ks get a brief: results, deals, executive changes, restructuring, impairments, delisting notices, restatements, cybersecurity incidents and other disclosed events. Routine filings (vote results, exhibits only) are skipped. Every JATT II Acquisition Corp. filing is on SEC EDGAR ↗. 8-K briefs of other companies →